Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35

United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

9 insiders · 7 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Thomas J. Schall

Director

$101.04K (1)

—

+$101.04K

74,530

0.115%

$339.98K

+2,470%

Peter Feinberg

Director

$86.90K (1)

—

+$86.90K

292,207

0.452%

$1.33M

+28.6%

Brett Matthew Hall

Chief Scientific Officer

$35.55K (2)

—

+$35.55K

382,531

0.591%

$1.74M

+10.6%

Harold Eugene Brakewood

Chief Business Officer

$24.99K (1)

—

+$24.99K

11,050

0.017%

$50.41K

+183.3%

Benjamin J. Zeskind

President and CEO

$10.95K (1)

—

+$10.95K

2,315,252

3.6%

$10.56M

+1.5%

Leah R Neufeld

Chief People Officer

$10.91K (1)

—

+$10.91K

29,598

0.046%

$135.02K

+195.1%

Mallory Morales

SVP Finance, CAO

—

—

—

27,533

0.043%

$125.60K

+116.2%

Diana Hausman

Director

—

—

—

5,500

0.009%

$25.09K

—

Michael Bookman

Chief Legal Officer, Secretary

—

—

—

4,870

0.008%

$22.22K

+26.5%